Nordic Capital to carve out BWXT’s medical business in $800m transaction
Nordic expects to scale BWXT's capabilties and market presense in radiopharmaceuticals.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
